GlassScriptPhysician profile
Gerald Ross Williams
NPI 1972531424
$6,816,596.47
in general payments reported to CMS, 2019-2025
11 companies · $1.0M in 2025
The $1.0M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.2M · 2020: $927K · 2021: $892K · 2022: $901K · 2023: $988K · 2024: $875K · 2025: $1.0M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.6M · Consulting Fee: $279K · Travel and Lodging: $34K · Food and Beverage: $1,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,595,019.86 |
| Consulting Fee | $279,375.00 |
| Travel and Lodging | $33,847.84 |
| Food and Beverage | $1,583.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $5,029,648.33 | 2019-2025 | Djo Surgical, Aircast |
| Depuy Synthes Products, INC. | $1,770,161.17 | 2019-2025 | Global |
| Insight Medical Systems, INC. | $13,258.32 | 2023 | Arvis |
| Shoulder Innovations, INC. | $2,309.07 | 2020-2024 | Inset System |
| Liberty Surgical INC. | $616.00 | 2020 | |
| Catalyst Orthoscience | $295.64 | 2019-2024 | Catalyst Csr Shoulder System, R1 Reverse Shoulder System |
| Exactech, INC. | $135.84 | 2021 | |
| Stryker Corporation | $69.02 | 2025 | Omega |
| Heraeus Medical, LLC. | $61.88 | 2024 | |
| Maruho Medical, INC. | $24.70 | 2019 | |
| Depuy Synthes Sales INC. | $16.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.